Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H30I3N3O9 |
| Molecular Weight | 849.191 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCN(CCO)C(=O)C1=C(I)C(C(=O)N(CCO)CCO)=C(I)C(C(=O)N(CCO)CCO)=C1I
InChI
InChIKey=KZYHGCLDUQBASN-UHFFFAOYSA-N
InChI=1S/C21H30I3N3O9/c22-16-13(19(34)25(1-7-28)2-8-29)17(23)15(21(36)27(5-11-32)6-12-33)18(24)14(16)20(35)26(3-9-30)4-10-31/h28-33H,1-12H2
| Molecular Formula | C21H30I3N3O9 |
| Molecular Weight | 849.191 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Iosimide is synthetic, nonionic, monomeric contrast medium patented by Schering A.-G. In clinical trial Iosimide exhibited no differences in comparison with Ioxaglate with respect to the contrast, the neurological status or the liver or renal tolerance. In examining cardiovascular tolerance there is only a slight tendency toward liver changes with Iosimide. Examination of the general tolerance, however, shows a statistically significant lower incidence of sensation of heat and pain with iosimide than with ioxaglate.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:53:13 GMT 2025
by
admin
on
Mon Mar 31 17:53:13 GMT 2025
|
| Record UNII |
3EL4NLE563
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
79211-10-2
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
5439
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
DTXSID20229579
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
279-110-8
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
C166675
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
100000083110
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
C047355
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
SUB08251MIG
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105004
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
3EL4NLE563
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY | |||
|
60911
Created by
admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |